Oliver Russell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oliver Russell has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Andre Kortum
Queen's Veterinary School Hospital University of Cambridge Cambridge UK
3 shared publications Andre Kortum
Department of Veterinary Medicine University of Cambridge Cambridge UK
2 shared publications- Barbara J. Skelly
Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, UK
2 shared publications A. Briggs
Langford Vets Langford UK
1 shared publicationAkash Alexander
The Queen’s Veterinary School Hospital Cambridge University Veterinary School, Cambridge, UK
1 shared publicationAmy Lord
Queens Veterinary School Hospital, University of Cambridge, Cambridge, UK
1 shared publication
Latest Publications
- Open Access
- 1 February 2026
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 87 (2) , 1-9
Diagnostic tests performed and prescribed prednisolone dose for a dog with immune-mediated polyarthritis vary across veterinary specialties
Objective: To compare the investigation, management, and outcome, including medication adverse effects, of nonassociative immune-mediated polyarthritis cases when referred to different specialist disciplines. Methods: A retrospective observational review of medical records from 4 United Kingdom referral centers (2018 through 2022) was conducted. Dogs were included if they had nondegenerative neutrophilic inflammation in synovial fluid from > 2 joints and associated disease was not evident. Data on clinical signs, diagnostic tests, treatment, and adverse effects were collected. Remission at 12 months and relapse were recorded. Results: 83 dogs met the inclusion data. Cases referred to internal medicine underwent more diagnostic procedures, received lower initial prednisolone doses, and were more commonly prescribed adjunctive immunosuppressives compared to neurology (effect size, 0.35; 95% CI, 0.1 to 0.57:OR, 4.7; 95% CI, 0.6 to 216) and orthopedics (effect size, 0.26; 95% CI, 0.02 to 0.53:OR, 4.0; 95% CI, 0.5 to 185). There was no significant difference in the frequency of adverse effects with prednisolone dose, referral service, or adjunct immunosuppressant use. Remission at 12 months was not significantly associated with referral service, corticosteroid dose, or adjunctive immunosuppressant use. Conclusions: The management of nonassociative immune-mediated polyarthritis varies significantly across specialist disciplines. Despite differences in treatment strategies, adverse effects were common and not significantly associated with corticosteroid dose or adjunct use. Clinical Relevance: Further controlled prospective studies should focus on optimizing treatment protocols to improve outcomes and minimize complications in this challenging disease.
- 1 February 2026
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 87 (2) , 1-9
Open AccessDiagnostic tests performed and prescribed prednisolone dose for a dog with immune-mediated polyarthritis vary across veterinary specialties
Objective: To compare the investigation, management, and outcome, including medication adverse effects, of nonassociative immune-mediated polyarthritis cases when referred to different specialist disciplines. Methods: A retrospective observational review of medical records from 4 United Kingdom referral centers (2018 through 2022) was conducted. Dogs were included if they had nondegenerative neutrophilic inflammation in synovial fluid from > 2 joints and associated disease was not evident. Data on clinical signs, diagnostic tests, treatment, and adverse effects were collected. Remission at 12 months and relapse were recorded. Results: 83 dogs met the inclusion data. Cases referred to internal medicine underwent more diagnostic procedures, received lower initial prednisolone doses, and were more commonly prescribed adjunctive immunosuppressives compared to neurology (effect size, 0.35; 95% CI, 0.1 to 0.57:OR, 4.7; 95% CI, 0.6 to 216) and orthopedics (effect size, 0.26; 95% CI, 0.02 to 0.53:OR, 4.0; 95% CI, 0.5 to 185). There was no significant difference in the frequency of adverse effects with prednisolone dose, referral service, or adjunct immunosuppressant use. Remission at 12 months was not significantly associated with referral service, corticosteroid dose, or adjunctive immunosuppressant use. Conclusions: The management of nonassociative immune-mediated polyarthritis varies significantly across specialist disciplines. Despite differences in treatment strategies, adverse effects were common and not significantly associated with corticosteroid dose or adjunct use. Clinical Relevance: Further controlled prospective studies should focus on optimizing treatment protocols to improve outcomes and minimize complications in this challenging disease.
- Open Access
- 1 December 2025
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 86 (12) , 1-10
Antimicrobial use differs between general practice and referral settings in United Kingdom companion animals: a 12-month prospective study
Objective: To characterize the use of antimicrobials and frequency of microbial identification testing in cases seen by companion animal general practitioners and a single United Kingdom (UK) internal medicine referral service. Methods: This was a prospective, observational study of animals referred to a single UK-based internal medicine referral service over a 12-month period. Information recorded at the time of presentation included presenting complaint, current medications, and whether a microbial identification test had been performed. At discharge, the same information was recorded again alongside the final diagnosis. Results: 516 dogs and cats were enrolled, and 22.9% of cases were receiving antimicrobials at the time of presentation compared to 22.0% of cases at the time of discharge. Cases receiving antimicrobials at admittance were 2.7 (95% CI, 1.7 to 4.3) times more likely to be discharged on antimicrobials. Postreferral respiratory and urinary cases were 7.3 times more likely (OR, 7.3; 95% CI, 3.6 to 15.0) and 4.2 times more likely (OR, 4.2; 95% CI, 1.9 to 9.4), respectively, to be discharged on antimicrobials. Bacterial culture was more commonly performed within the referral center (72.1%) than prior to referral (16.9%). Conclusions: Bacterial culture is performed more frequently by referral internal medicine clinicians than UK general practitioners. There are differences in the distribution of cases prescribed antimicrobials between these 2 groups of veterinarians. Clinical Relevance: This study provides information on antimicrobial prescribing patterns in companion animals across both general practice and referral settings in the UK. It highlights areas for antimicrobial stewardship improvement as well as identifies factors associated with antimicrobial prescription.
- 1 December 2025
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 86 (12) , 1-10
Open AccessAntimicrobial use differs between general practice and referral settings in United Kingdom companion animals: a 12-month prospective study
Objective: To characterize the use of antimicrobials and frequency of microbial identification testing in cases seen by companion animal general practitioners and a single United Kingdom (UK) internal medicine referral service. Methods: This was a prospective, observational study of animals referred to a single UK-based internal medicine referral service over a 12-month period. Information recorded at the time of presentation included presenting complaint, current medications, and whether a microbial identification test had been performed. At discharge, the same information was recorded again alongside the final diagnosis. Results: 516 dogs and cats were enrolled, and 22.9% of cases were receiving antimicrobials at the time of presentation compared to 22.0% of cases at the time of discharge. Cases receiving antimicrobials at admittance were 2.7 (95% CI, 1.7 to 4.3) times more likely to be discharged on antimicrobials. Postreferral respiratory and urinary cases were 7.3 times more likely (OR, 7.3; 95% CI, 3.6 to 15.0) and 4.2 times more likely (OR, 4.2; 95% CI, 1.9 to 9.4), respectively, to be discharged on antimicrobials. Bacterial culture was more commonly performed within the referral center (72.1%) than prior to referral (16.9%). Conclusions: Bacterial culture is performed more frequently by referral internal medicine clinicians than UK general practitioners. There are differences in the distribution of cases prescribed antimicrobials between these 2 groups of veterinarians. Clinical Relevance: This study provides information on antimicrobial prescribing patterns in companion animals across both general practice and referral settings in the UK. It highlights areas for antimicrobial stewardship improvement as well as identifies factors associated with antimicrobial prescription.
- Open Access
- 1 May 2025
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 39 (3) , e70076
Fungal Rhinosinusitis in Cats in the United Kingdom: 34 Cases (2013–2022)
Background: Fungal rhinosinusitis in cats is an uncommon condition with sparse literature regarding the presentation, causative agents, diagnosis, treatment, and prognosis within the UK. Hypothesis/Objectives: To describe and report the presenting clinical signs, diagnostic imaging findings, treatment approach, and outcome of cats diagnosed with fungal rhinosinusitis in the UK. Animals: Thirty-four client-owned cats were diagnosed with fungal rhinosinusitis. Methods: Retrospective multicenter observational study. Cases presenting at 10 UK referral centers between January 2013 and December 2022 were retrospectively recruited. Results: Median duration of clinical signs was 3 months (0.5-42-months). The most common signs were sneezing (27/34, 79%) and nasal discharge (21/34, 62%). Turbinate lysis was present in 27/34 cases (79%) and always involved the caudal nasal cavity. Osteolysis of the frontal bone, orbit, or cribriform plate was observed in 16/34 cases (47%). At least two tests from fungal culture, panfungal PCR, and histopathology were performed in all cases, and in 8/34 cases (24%) only one was positive. The treatment approach varied, with debridement, topical clotrimazole, and systemic azole therapy used alone or in various combinations, and repeat treatment occurred in 9/34 cases (26%). Clinical remission > 90 days after treatment was found in 9/24 cases (38%), but case fatality rates were low, with 3/34 cases (9%) dying with clinical disease during available follow-up. Conclusions and Clinical Importance: Fungal rhinosinusitis should be considered in cats of any age with clinical signs of nasal disease. The prognosis from this data appears guarded for cats with fungal rhinosinusitis, with less than 50% of cats achieving long-term clinical remission.
- 1 May 2025
- Published by Oxford University Press (OUP) in Journal of Veterinary Internal Medicine
- Vol. 39 (3) , e70076
Open AccessFungal Rhinosinusitis in Cats in the United Kingdom: 34 Cases (2013–2022)
Background: Fungal rhinosinusitis in cats is an uncommon condition with sparse literature regarding the presentation, causative agents, diagnosis, treatment, and prognosis within the UK. Hypothesis/Objectives: To describe and report the presenting clinical signs, diagnostic imaging findings, treatment approach, and outcome of cats diagnosed with fungal rhinosinusitis in the UK. Animals: Thirty-four client-owned cats were diagnosed with fungal rhinosinusitis. Methods: Retrospective multicenter observational study. Cases presenting at 10 UK referral centers between January 2013 and December 2022 were retrospectively recruited. Results: Median duration of clinical signs was 3 months (0.5-42-months). The most common signs were sneezing (27/34, 79%) and nasal discharge (21/34, 62%). Turbinate lysis was present in 27/34 cases (79%) and always involved the caudal nasal cavity. Osteolysis of the frontal bone, orbit, or cribriform plate was observed in 16/34 cases (47%). At least two tests from fungal culture, panfungal PCR, and histopathology were performed in all cases, and in 8/34 cases (24%) only one was positive. The treatment approach varied, with debridement, topical clotrimazole, and systemic azole therapy used alone or in various combinations, and repeat treatment occurred in 9/34 cases (26%). Clinical remission > 90 days after treatment was found in 9/24 cases (38%), but case fatality rates were low, with 3/34 cases (9%) dying with clinical disease during available follow-up. Conclusions and Clinical Importance: Fungal rhinosinusitis should be considered in cats of any age with clinical signs of nasal disease. The prognosis from this data appears guarded for cats with fungal rhinosinusitis, with less than 50% of cats achieving long-term clinical remission.
- Open Access
- 10 February 2025
- Published by Wiley in Veterinary Record Case Reports
- Vol. 13 (2)
Brucella canis in two juvenile labrador retriever littermates with no known travel history
Two labrador retriever littermates presented separately to investigate chronic lethargy and shifting lameness. In both cases, clinical examination revealed a multi‐limb lameness. Neither the patients nor their dam or sire had a travel history outside the UK. Imaging of the vertebral column in both cases was consistent with discospondylitis. Brucella canis serology demonstrated a rising antibody titre in Case 1 and a strong positive antibody titre in Case 2 (4+/3200), consistent with a diagnosis of B. canis . Due to concerns relating to the poor prognosis, antimicrobial stewardship and zoonotic risk, both patients were euthanased. Since 2020, the UK has seen a rise in cases of B. canis , with most cases having been in imported dogs. This case report highlights how B. canis should be considered in dogs with no travel history and identifies challenges relating to diagnosis and managing these cases in practice.
- 10 February 2025
- Published by Wiley in Veterinary Record Case Reports
- Vol. 13 (2)
Open AccessBrucella canis in two juvenile labrador retriever littermates with no known travel history
Two labrador retriever littermates presented separately to investigate chronic lethargy and shifting lameness. In both cases, clinical examination revealed a multi‐limb lameness. Neither the patients nor their dam or sire had a travel history outside the UK. Imaging of the vertebral column in both cases was consistent with discospondylitis. Brucella canis serology demonstrated a rising antibody titre in Case 1 and a strong positive antibody titre in Case 2 (4+/3200), consistent with a diagnosis of B. canis . Due to concerns relating to the poor prognosis, antimicrobial stewardship and zoonotic risk, both patients were euthanased. Since 2020, the UK has seen a rise in cases of B. canis , with most cases having been in imported dogs. This case report highlights how B. canis should be considered in dogs with no travel history and identifies challenges relating to diagnosis and managing these cases in practice.
- Open Access
- 30 December 2024
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (1) , e70188
A Case of Canine Sinonasal Aspergillus fumigatus Infection Associated With Intracranial Extension and Temporal Myositis
A 12‐year‐old terrier was referred for investigation of a 4‐month history of coughing, sneezing and nasal discharge. Clinical findings were consistent with sinonasal Aspergillus fumigatus infection with evidence of intracranial extension on computed tomography. Endoscopic debridement followed by topical clotrimazole and systemic antifungal therapy resulted in clinical improvement. Magnetic resonance imaging after 4 weeks showed reduced intracranial disease but demonstrated evidence of temporal myositis. Repeated debridement and topical treatment were performed at 4 and 8 weeks in conjunction with long‐term voriconazole therapy. Further interventions were declined; the dog remains clinically well after 4 months with unilateral nasal discharge. As in human patients, invasive subtypes of sinonasal aspergillosis may also occur in dogs and be associated with poorer response to treatment.
- 30 December 2024
- Published by Wiley in Veterinary Medicine and Science
- Vol. 11 (1) , e70188
Open AccessA Case of Canine Sinonasal Aspergillus fumigatus Infection Associated With Intracranial Extension and Temporal Myositis
A 12‐year‐old terrier was referred for investigation of a 4‐month history of coughing, sneezing and nasal discharge. Clinical findings were consistent with sinonasal Aspergillus fumigatus infection with evidence of intracranial extension on computed tomography. Endoscopic debridement followed by topical clotrimazole and systemic antifungal therapy resulted in clinical improvement. Magnetic resonance imaging after 4 weeks showed reduced intracranial disease but demonstrated evidence of temporal myositis. Repeated debridement and topical treatment were performed at 4 and 8 weeks in conjunction with long‐term voriconazole therapy. Further interventions were declined; the dog remains clinically well after 4 months with unilateral nasal discharge. As in human patients, invasive subtypes of sinonasal aspergillosis may also occur in dogs and be associated with poorer response to treatment.
- Open Access
- 12 November 2024
- Published by Wiley in Veterinary Record Case Reports
- Vol. 13 (1)
Suspected hepatic hydrothorax secondary to cirrhosis in a dog
An 8‐year‐old, entire, female labrador retriever presented with a 2‐week history of abdominal distension. Biochemistry identified hepatic dysfunction (elevated hepatobiliary markers, hypocholesterolaemia). Abdominal ultrasonography documented an irregular liver and a large volume of anechoic peritoneal effusion, which laboratory analysis confirmed as a protein‐poor transudate. Thoracic computed tomography identified a moderate volume of pleural effusion with a similar composition to the peritoneal fluid. Hepatic histopathology was consistent with cirrhosis secondary to chronic hepatitis and, in the absence of another cause for the pleural effusion, hydrothorax secondary to the hepatic disease was suspected. The patient was started on ciclosporin for treatment of the underlying liver disease, but developed signs consistent with disseminated intravascular coagulopathy 24 hours later and was humanely euthanased. As reported in humans, hydrothorax may therefore occur secondary to cirrhosis in dogs and should be considered as a differential diagnosis for pleural effusion in patients with advanced hepatic disease and concurrent peritoneal effusion.
- 12 November 2024
- Published by Wiley in Veterinary Record Case Reports
- Vol. 13 (1)
Open AccessSuspected hepatic hydrothorax secondary to cirrhosis in a dog
An 8‐year‐old, entire, female labrador retriever presented with a 2‐week history of abdominal distension. Biochemistry identified hepatic dysfunction (elevated hepatobiliary markers, hypocholesterolaemia). Abdominal ultrasonography documented an irregular liver and a large volume of anechoic peritoneal effusion, which laboratory analysis confirmed as a protein‐poor transudate. Thoracic computed tomography identified a moderate volume of pleural effusion with a similar composition to the peritoneal fluid. Hepatic histopathology was consistent with cirrhosis secondary to chronic hepatitis and, in the absence of another cause for the pleural effusion, hydrothorax secondary to the hepatic disease was suspected. The patient was started on ciclosporin for treatment of the underlying liver disease, but developed signs consistent with disseminated intravascular coagulopathy 24 hours later and was humanely euthanased. As reported in humans, hydrothorax may therefore occur secondary to cirrhosis in dogs and should be considered as a differential diagnosis for pleural effusion in patients with advanced hepatic disease and concurrent peritoneal effusion.
- 4 July 2024
- Published by Wiley in Journal of Small Animal Practice
- Vol. 65 (9) , 682-693
Assessment of alendronate and dietary treatment in the management of feline idiopathic ionised hypercalcaemia and ionised hypercalcaemia associated with chronic kidney disease: 29 cases (2016‐2022)
Objectives: This retrospective cohort multicentre study aimed to characterise the signalment, clinicopathologic data, complications and the association between treatment and outcome (the reduction in ionised calcium concentration) in cats with idiopathic or chronic kidney disease‐associated ionised hypercalcaemia managed with alendronate and standard treatment or standard treatment alone, and to compare the outcome between the two groups.Materials and Methods: Medical records for cats diagnosed with idiopathic or chronic kidney disease‐associated ionised hypercalcaemia were retrospectively reviewed. Cats treated with alendronate and standard treatment were assigned to the alendronate group and cats treated with standard treatment alone were assigned to the control group. The standard treatment was defined as dietary modification and/or monitoring of ionised calcium concentrations and management of complications secondary to hypercalcaemia. The follow‐up period was selected as 6 months.Results: Twenty‐nine cats were enrolled in the study. Nine cats were included in the control group and 20 cats in the alendronate group. A significant reduction in serum ionised calcium was observed in both groups between the baseline and the follow‐up visit; however, this reduction did not differ significantly between both groups (the mean change in the ionised calcium concentration in alendronate and control group was −0.18 and −0.17, respectively). Suspected bisphosphate‐related osteonecrosis of the jaw was reported in one cat receiving alendronate.Clinical Significance: In this study, similar reduction in serum ionised calcium concentration was observed in cats with ionised hypercalcaemia treated with diet alone and in cats treated with diet and alendronate. These results should be interpreted with caution, as the study was underpowered for meaningful statistical comparison. Cats receiving alendronate should be monitored for the development of adverse reactions, including osteonecrosis of the jaw.
- 4 July 2024
- Published by Wiley in Journal of Small Animal Practice
- Vol. 65 (9) , 682-693
Assessment of alendronate and dietary treatment in the management of feline idiopathic ionised hypercalcaemia and ionised hypercalcaemia associated with chronic kidney disease: 29 cases (2016‐2022)
Objectives: This retrospective cohort multicentre study aimed to characterise the signalment, clinicopathologic data, complications and the association between treatment and outcome (the reduction in ionised calcium concentration) in cats with idiopathic or chronic kidney disease‐associated ionised hypercalcaemia managed with alendronate and standard treatment or standard treatment alone, and to compare the outcome between the two groups.Materials and Methods: Medical records for cats diagnosed with idiopathic or chronic kidney disease‐associated ionised hypercalcaemia were retrospectively reviewed. Cats treated with alendronate and standard treatment were assigned to the alendronate group and cats treated with standard treatment alone were assigned to the control group. The standard treatment was defined as dietary modification and/or monitoring of ionised calcium concentrations and management of complications secondary to hypercalcaemia. The follow‐up period was selected as 6 months.Results: Twenty‐nine cats were enrolled in the study. Nine cats were included in the control group and 20 cats in the alendronate group. A significant reduction in serum ionised calcium was observed in both groups between the baseline and the follow‐up visit; however, this reduction did not differ significantly between both groups (the mean change in the ionised calcium concentration in alendronate and control group was −0.18 and −0.17, respectively). Suspected bisphosphate‐related osteonecrosis of the jaw was reported in one cat receiving alendronate.Clinical Significance: In this study, similar reduction in serum ionised calcium concentration was observed in cats with ionised hypercalcaemia treated with diet alone and in cats treated with diet and alendronate. These results should be interpreted with caution, as the study was underpowered for meaningful statistical comparison. Cats receiving alendronate should be monitored for the development of adverse reactions, including osteonecrosis of the jaw.
- Open Access
- 9 June 2024
- Published by Wiley in Veterinary Record Case Reports
- Vol. 12 (3)
Suspected hypocortisolaemia‐induced cardiac dysfunction and congestive heart failure in a dog with hypoadrenocorticism
A 3‐year‐old, female, neutered lurcher was presented with a 6‐day history of lethargy and hyporexia. Clinical examination documented evidence of dehydration and hypovolaemia, but was otherwise unremarkable, including cardiac and pulmonary auscultation. Clinicopathological results, thoracic radiography, abdominal ultrasound, electrocardiography and adrenocorticotropic hormone stimulation testing were consistent with hypoadrenocorticism and hypovolaemia. Following initial stabilisation with intravenous fluid therapy, mineralocorticoid and glucocorticoid replacement, the dog became acutely tachypnoeic, and repeat radiography revealed a marked, generalised alveolar lung pattern consistent with pulmonary oedema. Echocardiography documented left ventricular volume overload and mild left atrial enlargement with increased left ventricular filling pressures, suggestive of cardiac dysfunction and left‐sided congestive heart failure. Following initiation of furosemide and pimobendan, alongside desoxycortone pivalate and prednisolone therapy, left‐sided congestive heart failure resolved within 24 hours. Cardiac structure and function, and N‐terminal pro‐brain natriuretic peptide normalised over the following 2 months, enabling tapering and discontinuation of furosemide and pimobendan therapy.
- 9 June 2024
- Published by Wiley in Veterinary Record Case Reports
- Vol. 12 (3)
Open AccessSuspected hypocortisolaemia‐induced cardiac dysfunction and congestive heart failure in a dog with hypoadrenocorticism
A 3‐year‐old, female, neutered lurcher was presented with a 6‐day history of lethargy and hyporexia. Clinical examination documented evidence of dehydration and hypovolaemia, but was otherwise unremarkable, including cardiac and pulmonary auscultation. Clinicopathological results, thoracic radiography, abdominal ultrasound, electrocardiography and adrenocorticotropic hormone stimulation testing were consistent with hypoadrenocorticism and hypovolaemia. Following initial stabilisation with intravenous fluid therapy, mineralocorticoid and glucocorticoid replacement, the dog became acutely tachypnoeic, and repeat radiography revealed a marked, generalised alveolar lung pattern consistent with pulmonary oedema. Echocardiography documented left ventricular volume overload and mild left atrial enlargement with increased left ventricular filling pressures, suggestive of cardiac dysfunction and left‐sided congestive heart failure. Following initiation of furosemide and pimobendan, alongside desoxycortone pivalate and prednisolone therapy, left‐sided congestive heart failure resolved within 24 hours. Cardiac structure and function, and N‐terminal pro‐brain natriuretic peptide normalised over the following 2 months, enabling tapering and discontinuation of furosemide and pimobendan therapy.
- 1 January 2024
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 262 (1) , 1-7
Persistent urinary incontinence in female Golden Retrievers following laser ablation of intramural ectopic ureters may be associated with the presence of historical urinary tract infection
OBJECTIVE: To identify predictive factors for postoperative continence in female Golden Retrievers following cystoscopic-guided laser ablation of intramural ectopic ureters (CLA-EU). ANIMALS: 41 client-owned female entire Golden Retrievers with uni- or bilateral intramural ectopic ureter(s) were retrospectively enrolled. METHODS: Patients were diagnosed with ectopic ureters with a combination of ultrasonography and cystoscopy. CLA-EU was performed for all dogs so that each ureteral opening was considered to be in an appropriate position by a single operator. All dogs had short-term follow-up 4 weeks and long-term follow up > 10 weeks after the procedure via telephone, which included urinary continence scoring. Clinical factors and ultrasonographic and cystoscopic findings from initial presentation were evaluated to identify predictive factors for postoperative continence. RESULTS: Short-term urinary continence was achieved in 46.3% of dogs with no additional medical therapies. Presence of historical urinary tract infections prior to CLA-EU (OR, 0.130; 95% CI, 0.020 to 0.621; P = .018) was negatively correlated and ureteral dilatation (OR, 34.260; 95% CI, 1.813 to 2,143; P = .043) was positively correlated with likelihood of urinary continence. Long-term urinary continence was achieved in 63.4% of dogs, and presence of historical urinary tract infections was negatively prognostic (OR, 0.173; 95% CI, 0.023 to 0.856; P = .048). CLINICAL RELEVANCE: Female Golden Retrievers undergoing CLA-EU have similar outcomes to those reported for other mixed-breed cohorts with > 30% of dogs failing to regain urinary continence. Historical urinary tract infections were significantly associated with both short- and long-term urinary continence in our population.
- 1 January 2024
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 262 (1) , 1-7
Persistent urinary incontinence in female Golden Retrievers following laser ablation of intramural ectopic ureters may be associated with the presence of historical urinary tract infection
OBJECTIVE: To identify predictive factors for postoperative continence in female Golden Retrievers following cystoscopic-guided laser ablation of intramural ectopic ureters (CLA-EU). ANIMALS: 41 client-owned female entire Golden Retrievers with uni- or bilateral intramural ectopic ureter(s) were retrospectively enrolled. METHODS: Patients were diagnosed with ectopic ureters with a combination of ultrasonography and cystoscopy. CLA-EU was performed for all dogs so that each ureteral opening was considered to be in an appropriate position by a single operator. All dogs had short-term follow-up 4 weeks and long-term follow up > 10 weeks after the procedure via telephone, which included urinary continence scoring. Clinical factors and ultrasonographic and cystoscopic findings from initial presentation were evaluated to identify predictive factors for postoperative continence. RESULTS: Short-term urinary continence was achieved in 46.3% of dogs with no additional medical therapies. Presence of historical urinary tract infections prior to CLA-EU (OR, 0.130; 95% CI, 0.020 to 0.621; P = .018) was negatively correlated and ureteral dilatation (OR, 34.260; 95% CI, 1.813 to 2,143; P = .043) was positively correlated with likelihood of urinary continence. Long-term urinary continence was achieved in 63.4% of dogs, and presence of historical urinary tract infections was negatively prognostic (OR, 0.173; 95% CI, 0.023 to 0.856; P = .048). CLINICAL RELEVANCE: Female Golden Retrievers undergoing CLA-EU have similar outcomes to those reported for other mixed-breed cohorts with > 30% of dogs failing to regain urinary continence. Historical urinary tract infections were significantly associated with both short- and long-term urinary continence in our population.
- Open Access
- 1 July 2023
- Published by SAGE Publications in Journal of Feline Medicine and Surgery Open Reports
- Vol. 9 (2)
Clinical remission of feline sino-nasal aspergillosis despite evidence of persistent infection
Case summary: Feline sino-nasal aspergillosis is a rare condition with only sparse heterogeneous reports in the literature regarding its treatment. This report describes the presentation, treatment and outcome of a cat with sino-nasal aspergillosis treated by meticulous debridement in combination with topical and systemic azole therapy. Diagnosis was based on MRI, in combination with rhinoscopic assessment and visualisation of fungal plaques, followed by histopathology, fungal culture and panfungal PCR. The cat was treated by debridement of fungal plaques via anterior rhinoscopy and frontal sinusotomy and local instillation of 1% clotrimazole solution, followed by a 4-week course of oral itraconazole. Histopathology confirmed fungal rhinitis and culture identified Aspergillus fumigatus and Aspergillus versicolor. Clinical remission was achieved after treatment; however, evidence of persistent infection was confirmed in the post-mortem examination 8 months after the cat was euthanased for unrelated reasons. Relevance and novel information: Despite clinical remission, the persistence of fungal infection post mortem highlights the challenges of monitoring the response to treatment and illustrates that the resolution of clinical signs does not necessarily equate with a disease cure.
- 1 July 2023
- Published by SAGE Publications in Journal of Feline Medicine and Surgery Open Reports
- Vol. 9 (2)
Open AccessClinical remission of feline sino-nasal aspergillosis despite evidence of persistent infection
Case summary: Feline sino-nasal aspergillosis is a rare condition with only sparse heterogeneous reports in the literature regarding its treatment. This report describes the presentation, treatment and outcome of a cat with sino-nasal aspergillosis treated by meticulous debridement in combination with topical and systemic azole therapy. Diagnosis was based on MRI, in combination with rhinoscopic assessment and visualisation of fungal plaques, followed by histopathology, fungal culture and panfungal PCR. The cat was treated by debridement of fungal plaques via anterior rhinoscopy and frontal sinusotomy and local instillation of 1% clotrimazole solution, followed by a 4-week course of oral itraconazole. Histopathology confirmed fungal rhinitis and culture identified Aspergillus fumigatus and Aspergillus versicolor. Clinical remission was achieved after treatment; however, evidence of persistent infection was confirmed in the post-mortem examination 8 months after the cat was euthanased for unrelated reasons. Relevance and novel information: Despite clinical remission, the persistence of fungal infection post mortem highlights the challenges of monitoring the response to treatment and illustrates that the resolution of clinical signs does not necessarily equate with a disease cure.